Form 4 for IDYA IDEAYA Biosciences, Inc.
Accepted 2023-06-02 00:00:00 ET · period of report 2023-05-31 · accession 0001610717-23-000087 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DMT | 2023-06-02 | 2023-05-31+ | IDYA | Throne Jason | CLO | M - OptEx | $7.01 | +3,985 | 3,553 | New | +$27.9K |
| DMT | 2023-06-02 | 2023-05-31+ | IDYA | Throne Jason | CLO | S - Sale+OE | $23.02 | -3,985 | 0 | -100% | -$91.7K |
| DMT | 2023-06-02 | 2023-05-31+ | IDYA | Throne Jason | CLO | M - OptEx | $0.00 | -3,985 | 66.5K | -6% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-05-31 | M | A | 432 | $7.01 | 432 | D | — | — | |
| 2 | Common | Common Stock | 2023-05-31 | S | D | 432 | $23.00 | 0 | D | — | — | |
| 3 | Common | Common Stock | 2023-06-01 | M | A | 3,553 | $7.01 | 3,553 | D | — | — | |
| 4 | Common | Common Stock | 2023-06-01 | S | D | 3,553 | $23.02 | 0 | D | — | — | (F2) This transaction was executed in multiple trades in prices ranging from $23.00 to $23.05, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. |
| 5 | Derivative | Stock Option (Right to Buy) | 2023-06-01 | M | D | 3,553 | $0.00 | 62,905 | D | $7.01 · — to 2029-10-08 | 3,553 Common Stock | (F3) 25% of the shares subject to the option vest on the first anniversary measured from October 9, 2019 (the "Vesting Commencement Date"), and 1/48th of the total number of shares vest monthly thereafter, such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date. |
| 6 | Derivative | Stock Option (Right to Buy) | 2023-05-31 | M | D | 432 | $0.00 | 66,458 | D | $7.01 · — to 2029-10-08 | 432 Common Stock | (F3) 25% of the shares subject to the option vest on the first anniversary measured from October 9, 2019 (the "Vesting Commencement Date"), and 1/48th of the total number of shares vest monthly thereafter, such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date. |